Covered recipient · General Payments record
ANGELA CHRISTINE AMEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$598.33
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $444.48 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SI-BONE, INC. | $157.01 | 1 |
| Novo Nordisk AS | $92.42 | 4 |
| Lilly USA, LLC | $68.88 | 4 |
| ALK-Abello, Inc | $38.08 | 2 |
| ABBVIE INC. | $31.79 | 2 |
| Philips Electronics North America Corporation | $22.04 | 1 |
| Acella Pharmaceuticals, LLC | $19.45 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $14.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.02 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106435321 | CMS |
| ABBVIE INC. | $15.77 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106435323 | CMS |
| Acella Pharmaceuticals, LLC | $19.45 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126637136 | CMS |
| ALK-Abello, Inc | $22.25 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099888555 | CMS |
| ALK-Abello, Inc | $15.83 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099888553 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $14.81 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146787761 | CMS |
| Lilly USA, LLC | $14.95 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135533768 | CMS |
| Lilly USA, LLC | $16.44 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135511671 | CMS |
| Lilly USA, LLC | $16.44 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135447837 | CMS |
| Lilly USA, LLC | $21.05 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135533772 | CMS |
| Novo Nordisk Inc | $24.98 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100566074 | CMS |
| Novo Nordisk Inc | $23.99 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100415337 | CMS |
| Novo Nordisk Inc | $18.47 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100404634 | CMS |
| Novo Nordisk Inc | $24.98 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100267590 | CMS |
| Philips North America LLC | $22.04 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146883280 | CMS |
| SI-BONE, INC. | $157.01 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120073541 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.